$REGN Form 8-K

0
494

Form 8-K for REGENERON PHARMACEUTICALS INC


19-Feb-2016

Change in Directors or Principal Officers

Item 5.02. Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.On February 16, 2016, Douglas S. McCorkle notified Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) of his intention to retire from his position as Vice President, Controller and Assistant Treasurer of the Company in early 2017. Mr. McCorkle has served as Regeneron’s principal accounting officer since 1998.

LEAVE A REPLY

Please enter your comment!
Please enter your name here